Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Abstract A major challenge in coronavirus vaccination and treatment is to counteract rapid viral evolution and mutations. Here we demonstrate that CRISPR-Cas13d offers a broad-spectrum antiviral (BSA) to inhibit many SARS-CoV-2 variants and diverse human coronavirus strains with >99% reduction of th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Leiping Zeng, Yanxia Liu, Xammy Huu Wrynla, Timothy R. Abbott, Mengting Han, Yanyu Zhu, Augustine Chemparathy, Xueqiu Lin, Xinyi Chen, Haifeng Wang, Draven A. Rane, Jordan M. Spatz, Saket Jain, Arjun Rustagi, Benjamin Pinsky, Adrianna E. Zepeda, Anastasia P. Kadina, John A. Walker, Kevin Holden, Nigel Temperton, Jennifer R. Cochran, Annelise E. Barron, Michael D. Connolly, Catherine A. Blish, David B. Lewis, Sarah A. Stanley, Marie F. La Russa, Lei S. Qi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2022-05-01
coleção:	Nature Communications
Acesso em linha:	https://doi.org/10.1038/s41467-022-30546-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!